Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma of Skin Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableTemporarily pausedNCT06391099
What this trial is testing

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Cutaneous MelanomaMetastatic Renal Cell Carcinoma+1 more
Ohio State University Comprehensive Cancer Center 60
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Study completedNCT04570332
What this trial is testing

BO-112 With Pembrolizumab in Unresectable Malignant Melanoma

Who this might be right for
Melanoma
Highlight Therapeutics 42
Testing effectiveness (Phase 2)Study completedNCT02523313
What this trial is testing

Immunotherapy With Nivolumab or Nivolumab Plus Ipilimumab vs. Double Placebo for Stage IV Melanoma w. NED

Who this might be right for
Malignant Melanoma
Prof. Dr. med. Dirk Schadendorf 167
Early research (Phase 1)Active Not RecruitingNCT01590069
What this trial is testing

Aerosolized Aldesleukin in Treating Patients With Lung Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the LungMetastatic MelanomaMetastatic Osteosarcoma+5 more
M.D. Anderson Cancer Center 70
Very early researchStudy completedNCT04067960
What this trial is testing

Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+45 more
Mayo Clinic 197
Testing effectiveness (Phase 2)Ended earlyNCT00945269
What this trial is testing

Therapeutic Autologous Lymphocytes, Aldesleukin, and Denileukin Diftitox in Treating Patients With Stage III-IV Melanoma

Who this might be right for
Recurrent MelanomaStage III MelanomaStage IV Melanoma
Fred Hutchinson Cancer Center 3
Early research (Phase 1)Study completedNCT00091338
What this trial is testing

Interleukin-7 and Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT01888081
What this trial is testing

A-dmDT390-bisFv(UCHT1) Fusion Protein in Combination With Ionizing Radiation for Treatment of Stage IV Melanoma

Who this might be right for
Melanoma
Virogen Biotechnology Inc. 2
Testing effectiveness (Phase 2)Ended earlyNCT00145158
What this trial is testing

Immunization With 8 Peptides Mixed With CpG 7909 or Montanide ISA51 in Patients With Metastatic Cutaneous Melanoma

Who this might be right for
Malignant Melanoma
Ludwig Institute for Cancer Research 23
Testing effectiveness (Phase 2)Ended earlyNCT00006113
What this trial is testing

Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
University of Southern California 25
Testing effectiveness (Phase 2)UnknownNCT02142335
What this trial is testing

Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma

Who this might be right for
Malignant Melanoma of Skin Stage IIIMetastatic Melanoma
California Cancer Assocaties for Research & Excellence 17
Early research (Phase 1)Study completedNCT01176461
What this trial is testing

Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558

Who this might be right for
Melanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute 127
Not applicableNot Yet RecruitingNCT07689812
What this trial is testing

Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more
Natera, Inc. 920
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07340619
What this trial is testing

Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.

Who this might be right for
Metastatic (Stage IV) Melanoma
UNICANCER 51
Not applicableStudy completedNCT04670445
What this trial is testing

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer

Who this might be right for
Stage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more
Massachusetts General Hospital 199
Very early researchStudy completedNCT00962845
What this trial is testing

Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery

Who this might be right for
Melanoma (Skin)
Rutgers, The State University of New Jersey 20
Testing effectiveness (Phase 2)Study completedNCT00081042
What this trial is testing

ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00398073
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Memorial Sloan Kettering Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT00007969
What this trial is testing

Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
QLT Inc.
Next Page